Hugel (145020) Vs Medy Tox: Market Neutral Trade
Hugel Inc is undervalued with strong growth potential, while Medy Tox is neglecting core strategy for R&D. Long Hugel and Short Medy Tox strategy...
124 Views
Smartkarma’s Week That Was in JP/KR: Semiconductor Warnings, Exit of Chairman Cho, & 청년수당
In the past week, there were earnings warnings from three major players in the global semiconductor sector, including Samsung Electronics (005930...
797 Views
How Will South Korea Change With Moon as Its Next President? (Top 10 Issues)
Bonifas and Barrett may not be household names to most people. They were two US Army officers stationed in South Korea who were killed by North...
509 Views
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4.2k Views
SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing
SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...
3.6k Views